Stuart Davidson

Stuart Davidson "has been involved in investing in early stage companies for the past 12 years. He is a managing director of Labrador Ventures. He also directs the Phalarope Foundation, which focuses on enterprise development, and is a trustee of the Cancer Research Institute. Previously, Mr. Davidson was CEO of Combion, Inc., which was acquired by Incyte Pharmaceuticals (INCY), and president of Alkermes, Inc. (ALKS), a biotechnology company. Mr. Davidson also worked for MCI Communications and for Warner Communications, where he was responsible for the development of a number of information technology business opportunities. Mr. Davidson is a graduate of Harvard College and Harvard Business School." 


 * Director, Acumen Fund